Avenir Complete Post-Market Clinical Follow-Up Study
Global, Multicenter, and Prospective Post-Market Clinical Follow-Up Study of the Avenir Complete™ Femoral Stem (Implants and Instrumentation)
Sponsor: Zimmer Biomet
Listed as NCT04731077, this NA trial focuses on Avascular Necrosis of Hip and Avascular Necrosis of the Femoral Head and remains ongoing. Sponsored by Zimmer Biomet, it has been updated 10 times since 2021, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting NA
-
Jul 2025 — Sep 2025 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Jul 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Apr 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Jun 2023 — Apr 2024 [monthly]
Recruiting NA
-
Apr 2022 — Jun 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Nov 2021 — Apr 2022 [monthly]
Not Yet Recruiting NA
-
Sep 2021 — Nov 2021 [monthly]
Not Yet Recruiting NA
-
Feb 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Zimmer Biomet
For direct contact, visit the study record on ClinicalTrials.gov .